Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease
Phase 2
Completed
- Conditions
- Severe COVID-19 Disease
- Interventions
- Biological: Biological
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Hospital Central Militar
- Target Recruit Count
- 150
- Registration Number
- NCT04542967
- Locations
- 🇲🇽
Hospital Central Militar, Mexico City, Mexico
© Copyright 2025. All Rights Reserved by MedPath